Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
Tae Michael SCorporate VP, Corp. Strategy
GrantStock Option (Right to Buy) · Derivative 8,357 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002849 · doc4.xml · derivative · entry 1

Tae Michael S · CIK 0001663476 · Corporate VP, Corp. Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,357

Underlying: Common Stock · 8,357 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
SCHIFELLITE ROBERTCorporate Senior VP
GrantStock Option (Right to Buy) · Derivative 23,877 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002848 · doc4.xml · derivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,877

Underlying: Common Stock · 23,877 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC GrantStock Option (Right to Buy) · Derivative 16,714 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002847 · doc4.xml · derivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,714

Underlying: Common Stock · 16,714 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
MARCHESANI CHARLES JCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 13,132 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002844 · doc4.xml · derivative · entry 1

MARCHESANI CHARLES J · CIK 0001389951 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,132

Underlying: Common Stock · 13,132 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
KALENKA ROBERT FCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 8,357 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002842 · doc4.xml · derivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,357

Underlying: Common Stock · 8,357 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 8,357 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002840 · doc4.xml · derivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,357

Underlying: Common Stock · 8,357 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 14, 2018 19:35 UTC
AMSTERDAM ADAM DCorporate Vice President
GrantStock Option (Right to Buy) · Derivative 16,714 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-002838 · doc4.xml · derivative · entry 1

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,714

Underlying: Common Stock · 16,714 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 15, 2018 20:09 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 5,969 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-003025 · doc4.xml · derivative · entry 2

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,132

Underlying: Common Stock · 5,969 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
February 12, 2018 Filed Feb 15, 2018 20:09 UTC
Carey Thomas PCorporate VP
GrantStock Option (Right to Buy) · Derivative 7,163 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-18-003025 · doc4.xml · derivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,163

Underlying: Common Stock · 7,163 shares

Expires 2028-02-12

F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 12, 2019.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 17:23 UTC GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000539 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,334

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 12:23 UTC GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000540 · doc4.xml · nonDerivative · entry 1

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,884

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 12:23 UTC GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000544 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,334

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 12:23 UTC GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000542 · doc4.xml · nonDerivative · entry 1

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,858

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 12:23 UTC
WEBER ALAN JDirector
GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000545 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,534

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 17:23 UTC
keller brettDirector
GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000541 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,729

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 12:23 UTC GrantCommon Stock 83 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000538 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,246

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 17:23 UTC GrantCommon Stock 34 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000543 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,545

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
January 03, 2018 Filed Jan 4, 2018 21:45 UTC GrantCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001225208-18-000676 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 866

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
December 31, 2017 Filed Jan 3, 2018 15:33 UTC GrantPhantom Stock · Derivative 248.3992 $90.58 $22,500.00
Disclosure

SEC source: 0001225208-18-000112 · doc4.xml · derivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,422.9315

Underlying: Common Stock · 248.3992 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash upon the reporting person's separation from service as a director.

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash upon the reporting person's separation from service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash upon the reporting person's separation from service as a director.

Read SEC document
December 08, 2017 Filed Dec 11, 2017 19:42 UTC
SCHIFELLITE ROBERTCorporate Senior VP
Exercise / conversionStock Option (Right to Buy) · Derivative 59,698 $0.00 Strike: $24.25 $0.00
Disclosure

SEC source: 0001225208-17-018451 · doc4.xml · derivative · entry 3

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,698 shares

Expires 2022-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2017 Filed Dec 11, 2017 19:42 UTC
SCHIFELLITE ROBERTCorporate Senior VP
SaleCommon Stock 49,181 $89.47 $4,400,371.61
Disclosure

SEC source: 0001225208-17-018451 · doc4.xml · nonDerivative · entry 2

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,999.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.34 - $89.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 08, 2017 Filed Dec 11, 2017 19:42 UTC
SCHIFELLITE ROBERTCorporate Senior VP
Exercise / conversionCommon Stock 59,698 $24.25 $1,447,676.50
Disclosure

SEC source: 0001225208-17-018451 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,180.6729

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2017 Filed Dec 7, 2017 10:17 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,600 $0.00 Strike: $18.96 $0.00
Disclosure

SEC source: 0001225208-17-018339 · doc4.xml · derivative · entry 3

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,600 shares

Expires 2018-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2017 Filed Dec 7, 2017 10:17 UTC SaleCommon Stock 7,655 $88.51 $677,540.22
Disclosure

SEC source: 0001225208-17-018339 · doc4.xml · nonDerivative · entry 2

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,827

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.45 - $88.59, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 06, 2017 Filed Dec 7, 2017 10:17 UTC Exercise / conversionCommon Stock 12,600 $18.96 $238,896.00
Disclosure

SEC source: 0001225208-17-018339 · doc4.xml · nonDerivative · entry 1

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,482

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017510 · doc4.xml · derivative · entry 2

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017510 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,277

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017511 · doc4.xml · derivative · entry 2

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017511 · doc4.xml · nonDerivative · entry 1

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,882

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017515 · doc4.xml · derivative · entry 2

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017515 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,277

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017513 · doc4.xml · derivative · entry 2

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017513 · doc4.xml · nonDerivative · entry 1

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,801

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC
WEBER ALAN JDirector
GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017516 · doc4.xml · derivative · entry 2

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:14 UTC
WEBER ALAN JDirector
GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017516 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,477

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC
keller brettDirector
GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017512 · doc4.xml · derivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC
keller brettDirector
GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017512 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,715

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:13 UTC GrantStock Option (Right to Buy) · Derivative 5,735 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017508 · doc4.xml · derivative · entry 2

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,735

Underlying: Common Stock · 5,735 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 15:13 UTC GrantCommon Stock 1,205 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017508 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,163

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017514 · doc4.xml · derivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:14 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017514 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,511

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:13 UTC GrantStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-17-017509 · doc4.xml · derivative · entry 2

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,107

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 20:13 UTC GrantCommon Stock 863 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017509 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 863

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2017 Filed Nov 14, 2017 20:16 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionRestricted Stock Unit · Derivative 2,460 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017285 · doc4.xml · derivative · entry 3

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,461

Underlying: Common Stock · 2,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on November 13, 2017 2,460 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on November 13, 2017 2,460 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on November 13, 2017 2,460 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on November 13, 2017 2,460 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
November 13, 2017 Filed Nov 14, 2017 20:16 UTC
Taylor Julie R.Corporate VP and CHRO
Tax withholdingCommon Stock 910 $88.45 $80,489.50
Disclosure

SEC source: 0001225208-17-017285 · doc4.xml · nonDerivative · entry 2

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,803.327

Read SEC document
November 13, 2017 Filed Nov 14, 2017 20:16 UTC
Taylor Julie R.Corporate VP and CHRO
Exercise / conversionCommon Stock 2,460 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-017285 · doc4.xml · nonDerivative · entry 1

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,713.327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on November 13, 2017 2,460 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
October 11, 2017 Filed Oct 12, 2017 11:58 UTC
DALY RICHARD JDirector · President and CEO
SaleCommon Stock 42,822 $81.94 $3,508,680.52
Disclosure

SEC source: 0001225208-17-016221 · doc4.xml · nonDerivative · entry 2

DALY RICHARD J · CIK 0001198860 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,951.0229

F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 6, 2017.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.72 - $82.19, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
October 10, 2017 Filed Oct 12, 2017 11:58 UTC
DALY RICHARD JDirector · President and CEO
SaleCommon Stock 51,217 $81.95 $4,197,345.83
Disclosure

SEC source: 0001225208-17-016221 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,773.0229

F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 6, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.73 - $82.29, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
October 03, 2017 Filed Oct 4, 2017 16:20 UTC GrantCommon Stock 59 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-015891 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,414

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2017 Filed Oct 4, 2017 12:20 UTC GrantCommon Stock 59 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-015892 · doc4.xml · nonDerivative · entry 1

Haviland Richard J · CIK 0001302903 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,019

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2007 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.